M&A

JNJ, Actelion Reportedly Move Closer to a Deal
TheStreet.com
Thu, 01/12/17 - 09:20 am
JNJ
Actelion
M&A
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Motley Fool
Thu, 01/12/17 - 09:19 am
Pfizer
JPMHC 2017
M&A
competition
taxes
Ibrance
Pfizer wants deals that can pad sales 'now or soon.' And it's not waiting for tax reform
Fierce Pharma
Wed, 01/11/17 - 10:08 am
Pfizer
M&A
JPMHC 2017
taxes
Allergan Hints It Is Ready to Make a Splash for More Near-term Growth
TheStreet.com
Wed, 01/11/17 - 10:04 am
Allergan
Brent Saunders
Pharma CEOs
M&A
JPMHC 2017
JPM: Valeant sells off Dendreon, skincare brands for $2.1B
BioPharma Dive
Wed, 01/11/17 - 09:58 am
Valeant Pharmaceuticals
Dendreon
M&A
JPMHC 2017
Chinese Sanpower Group
Japan's Takeda ready for fresh acquisitions after $5.2 bln Ariad deal
Yahoo/Reuters
Wed, 01/11/17 - 09:55 am
Takeda
Ariad Pharma
M&A
2 Reasons Pfizer's Stock Beat the Field in 2016
Motley Fool
Tue, 01/10/17 - 09:10 am
Pfizer
M&A
taxes
Sanofi Sees No Opening to Actelion Talks After J&J Re-Entry
Bloomberg
Tue, 01/10/17 - 09:08 am
Sanofi
Actelion
JNJ
M&A
Takeda Pharmaceutical to buy Ariad in $5.2 billion cash deal
Yahoo/AP
Mon, 01/9/17 - 10:13 am
Takeda
Ariad Pharmaceuticals
M&A
Report: Pharma M&A may see 'banner year' in 2017
BioPharma Dive
Mon, 01/9/17 - 10:08 am
M&A
3 Takeover Candidates in the Drug Space
TheStreet.com
Mon, 01/9/17 - 09:45 am
M&A
Gilead Sciences
JNJ
Pfizer
Merck
Novartis
Eli Lilly
Bristol-Myers Squibb
Biogen
Pfizer agrees to $100m haircut in Hospira infusion sale to ICU Medical
Mass Device
Sat, 01/7/17 - 12:13 pm
Pfizer
Hospira
ICU Medical
devices
M&A
17 Thoughts on Biotech Stocks to Kick Off 2017
TheStreet.com
Sat, 01/7/17 - 12:04 pm
biotech
M&A
drug pricing
Donald Trump
Celgene
FDA
taxes
IPOs
clinical trials
M&A inflation just pushed the average biopharma valuation to a scary new peak
Endpoints
Thu, 01/5/17 - 10:08 am
M&A
biotech
Valeant Is A Strong Acquisition Target
Seeking Alpha
Thu, 01/5/17 - 09:36 am
Valeant Pharmaceuticals
M&A
Gilead Sciences
Pfizer
Amgen
Abbott closes $25B St. Jude buy
Mass Device
Thu, 01/5/17 - 09:07 am
Abbott Labs
St. Jude Medical
devices
M&A
J&J and Actelion's potential deal fix? $260 per share for marketed meds, spinoff for pipeline
Fierce Pharma
Wed, 01/4/17 - 10:46 am
JNJ
Actelion
M&A
New Details Emerge in Johnson & Johnson's Pursuit of Actelion
Motley Fool
Tue, 01/3/17 - 05:23 pm
JNJ
Actelion
M&A
Sanofi
Trump Tax Holiday May Fuel Drug M&A Boom
Investopedia
Tue, 01/3/17 - 12:01 pm
Donald Trump
taxes
M&A
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
biotech
M&A
drug launches
Gilead Sciences
Incyte
Spinraza
Biogen
Ionis Pharmaceuticals
Amgen
Regeneron
Sanofi

Pages